RC: Can a Master Switch Stop Cancer? with Stacy Blain, Co-founder, CSO, and CEO of CONCARLO Therapeutics
Targeting the Master Switch in Cancer Research.
In this episode, Stacy Blain talks about her personal history and how she got involved in clinical research and biotech, touching upon CONCARLO’s focus on developing a transformative cancer therapy targeting the p27 protein. She discusses the challenge of scaling up research, transitioning it into a consistent, scalable, and stable product for human trials while remaining optimistic about the power of science to bring new treatments to patients.
Tune in to learn about CONCARLO’s revolutionizing cancer research!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
